Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia
The DOI matches its Crossref record; 346 of the 351 references it cites were found in a registry or an index.
Abstract
A novel mechanism for regulating dopamine activity in subcortical sites and its possible relevance to schizophrenia is proposed. This hypothesis is based on the regulation of dopamine release into subcortical regions occurring via two independent mechanisms: (1) transient or phasic dopamine release caused by dopamine neuron firing, and (2) sustained, "background" tonic dopamine release regulated by prefrontal cortical afferents. Behaviorally relevant stimuli are proposed to cause short-term activation of dopamine cell firing to trigger the phasic component of dopamine release. In contrast, tonic dopamine release is proposed to regulate the intensity of the phasic dopamine response through its effect on extracellular dopamine levels. In this way, tonic dopamine release would set the background level of dopamine receptor stimulation (both autoreceptor and postsynaptic) and, through homeostatic mechanisms, the responsivity of the system to dopamine in these sites. In schizophrenics, a prolonged decrease in prefrontal cortical activity is proposed to reduce tonic dopamine release. Over time, this would elicit homeostatic compensations that would increase overall dopamine responsivity and thereby cause subsequent phasic dopamine release to elicit abnormally large responses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Available evidence suggests that a phasic DA imbalance, similar to that seen in schizophrenia, may help to explain the pathophysiology of TS [619,620].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [620]
Citations
Cites
Plum, F. (1960) · Archives of Neurology · doi:10.1001/archneur.1960.03840090124020 · Cited by 10,364
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Glycine potentiates the NMDA response in cultured mouse brain neurons
Johnson, J. W., & Ascher, P. (1987) · Nature · doi:10.1038/325529a0 · Cited by 3,139
Taussig, M. (2012) · Routledge eBooks · doi:10.4324/9780203397244 · Cited by 2,532
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Carlsson, A., & Lindqvist, M. (1963) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1963.tb01730.x · Cited by 2,148
Schizotaxia, schizotypy, schizophrenia.
Meehl, P. E. (1962) · American Psychologist · doi:10.1037/h0041029 · Cited by 2,019
Weinberger, D. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020020004 · Cited by 2,019
Psychopharmacology: The Third Generation of Progress.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-509_2 · Cited by 2,014
Research works printed but not linked: 17
- Abercrombie, 1989, In vivo biochemical correlates of acute depolarization inactivation in substantia nigra dopaminergic neurons, Soc. Neurosci. Abstr., 15, 1002
- Alpert, 1983, Comparison of affects in Parkinson's disease and schizophrenia, Psychopharmac. Bull., 19, 118
- Bayer, 1989, Somatic and dendritic basis for dopaminergic modulation in the ventral tegmental area, Soc. Neurosci. Abstr., 15, 1229
- Bonatz, 1989, l-DOPA produces higher levels of extracellular dopamine in dopamine depleted vs. intact striata, Soc. Neurosci. Abstr., 15, 124
- Clark, 1988, Effects of dopamine depletion of the prefrontal cortex on stress-induced changes in mesolimbic and striatal dopamine function, Soc. Neurosci. Abstr., 14, 1214
- Ferris, 1972, J. Pharmac. exp. Ther., 181, 407
- Grace, 1989, Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia, Soc. Neurosci. Abstr., 15, 1002
- Gross, 1974, Clozapin in der Langzeittherapie der chronischen Schizophrenie, Arzneimittelforschung, 24, 987
- Honigfield, 1984, Clozapine, antipsychotic activity in treatment-resistant schizophrenics, Adv. Ther., 1, 77
- Hornykiewicz, 1963, Die topische Lokalisation und das Verhalten von Noradrenalin und Dopamin (3-Hydroxytyramin) in der Substantia nigra des Normalin und Parkinsonkranken Menschen, Wein. Klin. Wschr., 75, 309
- Inanaga, 1975, Double-blind controlled study ofl-Dopa therapy in schizophrenia, Folia psychiat. neural. jap., 26, 145
- Leccese, 1987, Lesions of the medial prefrontal cortex dopamine neurons: effects on amphetamine self-administration and dopamine synthesis in the rat, Soc. Neurosci. Abstr., 13, 217
- Ogura, 1976, Clinical effects ofl-DOPA on schizophrenia, Curr. Ther. Res., 20, 308
- Rosin, 1987, Alterations in subcortical dopaminergic function following dopamine depletion in the medial prefrontal cortex, Soc. Neurosci. Abstr., 13, 1364
- Sesack, 1989, Ultrastructural basis for modulatory interactions between hippocampal and dopaminergic afferents to the rat nucleus accumbens, Soc. Neurosci. Abstr., 15, 1229
- Snyder, 1986, Release of endogenous DA and DOPAC from striatal slices after DA-depleting lesions: effects of stimulating frequency and DA synthesis inhibition, Soc. Neurosci. Abstr., 12, 136
- Von Voightlander, 1973, Involvement of nigrostriatal neurons in the in vivo release of dopamine by amphetamine, amantacline and tyramine, J. Pharmac. exp. Ther., 184, 542
Cited by
The adolescent brain and age-related behavioral manifestations
Spear, L. P. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00014-2 · Cited by 5,433
“[593,594]) and ignores, for example, the important distinction between tonic and phasic DA release in subcortical DA terminal regions [213,373].”
Predictive reward signal of dopamine neurons
Schultz, W. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.1.1 · Cited by 4,564
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
Berridge, K. C., & Robinson, T. E. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00019-8 · Cited by 4,127
Kapur, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.13 · Cited by 2,813
Dopamine in motivational control: rewarding, aversive, and alerting
Bromberg-Martin, E. S., Matsumoto, M., & Hikosaka, O. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.022 · Cited by 2,396
Metadata
- Authors
- Grace, A. A.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Grace, A.A.
- ORCID
- Grace, A.A.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 1991-01
- Volume
- 41
- Issue
- 1
- Pages
- 1-24
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W2126680030
- Cited by
- 1,831
- References
- 351
- Citations by year
- 2026: 22 · 2025: 26 · 2024: 38 · 2023: 39 · 2022: 40 · 2021: 36 · 2020: 40 · 2019: 39 · 2018: 51 · 2017: 43 · 2016: 47 · 2015: 64 · 2014: 65 · 2013: 85 · 2012: 75
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01mh042217-08)
- National Institute of Mental Health (MH 45156, MH42217, P50MH045156)
- National Institute of Neurological Disorders and Stroke (NS 19608)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- phasic dopamine release, tonic dopamine release, etiology of schizophrenia, extracellular dopamine
- MeSH terms
- Afferent Pathways, Animals, Cerebral Cortex, Corpus Striatum, Dopamine, Glutamates, Hallucinogens, Homeostasis, Humans, Models, Neurological, Models, Psychological, Synaptic Transmission, Neurons, Nucleus Accumbens, Receptors, Dopamine, Schizophrenia, Secretory Rate, Stress, Psychological, Antipsychotic Agents, Up-Regulation, Receptors, Glutamate, Receptors, Neurotransmitter, Glutamic Acid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia. https://app.cochat.ai/papers/10.1016/0306-4522(91)90196-u
- The paper
- Grace, A. A. (1991). Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia. Neuroscience. https://doi.org/10.1016/0306-4522(91)90196-u
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.